Search results for "randomized"

showing 10 items of 2323 documents

Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet.

1991

International audience; To determine whether an elemental diet or a polymeric defined formula diet would be more effective for treating active Crohn's disease, we conducted a prospective randomised clinical trial in 30 patients with active Crohn's disease unresponsive to steroids and/or complicated by malnutrition. They received a four to six week enteral nutrition course with either an elemental diet or a polymeric diet. Clinical remission occurred in 10 of the 15 patients on elemental diet compared with 11 of the 15 patients assigned to polymeric diet. Both groups showed similar improvements in nutritional status, biological inflammation, alpha 1 antitrypsin clearance, and colonoscopic le…

AdultMalemedicine.medical_specialtyElemental dietColon030309 nutrition & dieteticsNutritional StatusEnteral administrationGastroenterologylaw.invention03 medical and health sciencesEnteral Nutrition0302 clinical medicineCrohn DiseaseRandomized controlled trial[ CHIM.ORGA ] Chemical Sciences/Organic chemistrylawInternal medicinemedicineHumansProspective StudiesProspective cohort studyFood Formulated2. Zero hunger0303 health sciencesCrohn's disease[CHIM.ORGA]Chemical Sciences/Organic chemistrybusiness.industryGastroenterologyColonoscopymedicine.disease[CHIM.ORGA] Chemical Sciences/Organic chemistry3. Good healthClinical trialMalnutritionParenteral nutritionFemale030211 gastroenterology & hepatologybusinessResearch ArticleFollow-Up Studies
researchProduct

In vivo endomicroscopy improves detection of Barrett’s esophagus–related neoplasia: a multicenter international randomized controlled trial

2013

Background Confocal laser endomicroscopy (CLE) enables in vivo microscopic imaging of the GI tract mucosa. However, there are limited data on endoscope-based CLE (eCLE) for imaging Barrett's esophagus (BE). Objective To compare high-definition white-light endoscopy (HDWLE) alone with random biopsy (RB) and HDWLE + eCLE and targeted biopsy (TB) for diagnosis of BE neoplasia. Design Multicenter, randomized, controlled trial. Setting Academic medical centers. Patients Adult patients with BE undergoing routine surveillance or referred for early neoplasia. Intervention Patients were randomized to HDWLE + RB (group 1) or HDWLE + eCLE + TB (group 2). Real-time diagnoses and management plans were r…

AdultMalemedicine.medical_specialtyEndoscopeEsophageal NeoplasmsBiopsySpectrum Analysis RamanArticlelaw.inventionBarrett EsophagusEsophagusRandomized controlled triallawBiopsyEndomicroscopyMedicineHumansRadiology Nuclear Medicine and imagingSingle-Blind MethodProspective StudiesAgedAged 80 and overMicroscopy Confocalmedicine.diagnostic_testbusiness.industryGastroenterologyReproducibility of ResultsMiddle Agedmedicine.diseaseImage EnhancementEndoscopyClinical trialBarrett's esophagusCurrent Procedural TerminologyFemaleRadiologyEsophagoscopybusinessPrecancerous ConditionsFollow-Up Studies
researchProduct

Hemostatic Agents in Periapical Surgery: A Randomized Study of Gauze Impregnated in Epinephrine versus Aluminum Chloride

2016

Abstract Introduction Adequate bleeding control is essential for the success of periapical surgery. The aim of this study was to evaluate the effects of 2 hemostatic agents on the outcome of periapical surgery and their relationship with patient and teeth parameters. Methods A prospective study was designed with 2 randomized parallel groups, depending on the hemostatic agent used: gauze impregnated in epinephrine (epinephrine group) and aluminum chloride (aluminum chloride group). The analysis of the hemorrhage control was judged before and after the application of the hemostatic agents by the surgeon, and 2 examiners independently recorded it as adequate (complete hemorrhage control) or in…

AdultMalemedicine.medical_specialtyEpinephrineChlorideHemostaticsEndodonticslaw.invention03 medical and health sciences0302 clinical medicineBleeding controlChloridesRandomized controlled triallawmedicineAluminum ChlorideHumansVasoconstrictor Agents030212 general & internal medicineTooth RootAluminum CompoundsProspective cohort studyGeneral DentistryHemostatic Agentbusiness.industryPeriapical Diseases030206 dentistryMiddle AgedSurgeryLogistic ModelsTreatment OutcomeEpinephrineAnesthesiaHemostasisFemalebusinessPeriapical surgerymedicine.drugJournal of Endodontics
researchProduct

Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, ev…

2011

Hyaluronic acid (HA) fillers such as Restylane(®) are frequently used for the correction of facial soft tissue defects.To compare the efficacy and safety of a novel HA filler, Emervel(®) Classic, with those of Restylane in the treatment of moderate nasolabial folds.This was a split-face, randomized and evaluator-blinded comparison study. Subjects were randomized to receive an injection of Emervel Classic or Restylane on their left or right side. Efficacy was evaluated based on the change in Wrinkle Severity Rating Score (WSRS) from baseline. Local tolerability was assessed based on subject diary, which recorded the severity of erythema, oedema/swelling, bruising, pain/tenderness and pruritu…

AdultMalemedicine.medical_specialtyErythemaRestylaneCosmetic TechniquesDermatologylaw.inventionchemistry.chemical_compoundRandomized controlled triallawHyaluronic acidSubject DiarymedicineHumansSingle-Blind MethodHyaluronic AcidWrinklebusiness.industrySoft tissueMiddle AgedSkin AgingSurgerychemistryTolerabilityFemaleSurgerymedicine.symptombusinessJournal of Cosmetic and Laser Therapy
researchProduct

Impact of the WHO depression guideline on patient care by psychiatrists: a randomized controlled trial.

2008

AbstractBackgroundScientific literature reviews aim to summarize the state of knowledge and published empirical evidence. In contrast, medical guidelines are intervention tools that aim to improve physician behaviour and patient outcome. They can have positive effects, but they can also have negative effects. Their effects must be tested by research.MethodsIn a randomized controlled trial, 103 psychiatrists in private practice were either provided with the WHO depression guideline only (information group), or provided with the WHO depression guideline and trained for one day in this guideline (intervention group), or left uninformed (control group). They then treated a total of 497 patients…

AdultMalemedicine.medical_specialtyEvidence-based practiceInservice TrainingMirtazapineMianserinAntidepressive Agents TricyclicWorld Health Organizationlaw.invention03 medical and health sciences0302 clinical medicineContinuing medical educationRandomized controlled triallawGermanymedicineHumans030212 general & internal medicinePsychiatryAgedPsychiatryDepressive Disorderbusiness.industryEvidence-based medicineGuidelineMiddle AgedMental health030227 psychiatryPsychiatry and Mental healthAffectPrivate practicePractice Guidelines as TopicPhysical therapyFemalebusinessPsychosocialEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct

Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study.

1986

Forty patients with Graves' ophthalmopathy stages III-V were divided into two groups in a random manner according to their year of birth. Group I received prednisone in decreasing dosage. Group II received prednisone at a comparable dosage and ciclosporin. Steroids were discontinued after 10 weeks in the two groups. In the patients of group II, ciclosporin was continued over 12 months. The therapeutic effect was assessed by an activity score based on subjective and objective symptoms (computerized tomography and sonography of the orbit, Hertel values, clinical findings). All signs of endocrine ophthalmopathy improved significantly in both groups (P less than 0.01 in group I; P less than 0.0…

AdultMalemedicine.medical_specialtyEye DiseasesClinical BiochemistryVisual AcuityCyclosporinsBiochemistryGastroenterologylaw.inventionGraves' ophthalmopathyPharmacotherapyRandomized controlled triallawPrednisoneInternal medicinemedicineHumansProspective StudiesProspective cohort studyClinical Trials as TopicDose-Response Relationship Drugbusiness.industryTherapeutic effectGeneral MedicineMiddle AgedCiclosporinmedicine.diseaseGraves DiseaseClinical trialEndocrinologyPrednisoneDrug Therapy CombinationFemalebusinessmedicine.drugFollow-Up StudiesEuropean journal of clinical investigation
researchProduct

Effect of manual therapy versus proprioceptive neuromuscular facilitation in dynamic balance, mobility and flexibility in field hockey players. A ran…

2018

To compare the effectiveness of a specific Manual Therapy (MT) protocol applied to field hockey players (FHP), versus a Proprioceptive Neuromuscular Facilitation (PNF) protocol, in the improvement of dynamic balance, active range of movement and lumbar flexibility one-week and four-weeks after the treatment.Randomized controlled trial. Participants were assigned to 2 groups: MT and PNF. 30 min' sessions were performed once a week for three weeks. Three evaluations were performed: basal, one-week and four-weeks post-treatment.University of Valencia (Spain).22 in MT group and 20 in PNF group.Dynamic Balance, measured with Star Excursion Balance Test; Active Range of Motion (ROM), using a manu…

AdultMalemedicine.medical_specialtyFlexibility (anatomy)Field hockeyAdolescentPhysical Therapy Sports Therapy and Rehabilitationlaw.invention03 medical and health sciencesYoung Adult0302 clinical medicinePhysical medicine and rehabilitationRandomized controlled triallawMuscle Stretching ExercisesmedicineHumansOrthopedics and Sports MedicineKneeRange of Motion ArticularDynamic balancePostural Balance030222 orthopedicsHipProprioceptionArthrometry Articularbusiness.industryLumbosacral Region030229 sport sciencesGeneral MedicineProprioceptionMusculoskeletal ManipulationsBiomechanical Phenomenamedicine.anatomical_structureHockeyAthletesAthletic InjuriesFemaleManual therapyAnkleAnklebusinessRange of motionPhysical therapy in sport : official journal of the Association of Chartered Physiotherapists in Sports Medicine
researchProduct

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial

2004

We assessed the effectiveness and safety of an induction dose of peginterferon alfa-2b (PEG-IFN) plus ribavirin for initial treatment of patients with genotype 1 chronic HCV infection in a randomized, controlled, multicenter trial.Three hundred and eleven naïve patients infected with genotype 1 and chronic hepatitis were randomly assigned to 48-week treatment with PEG-IFN once weekly (80-100 micrograms depending on body weight for 8 weeks, followed by 50 micrograms for the next 40 weeks), or standard interferon alfa-2b (IFN) 6 million units on alternate days, both in combination with ribavirin (1000-1200 mg/day).PEG-IFN plus ribavirin significantly increased sustained virological response (…

AdultMalemedicine.medical_specialtyGenotypeCombination therapyFibrosiHepacivirusAlpha interferonHepacivirusInterferon alpha-2Antiviral AgentsGastroenterologyPolyethylene Glycolslaw.inventionchemistry.chemical_compoundRandomized controlled triallawMulticenter trialInternal medicineRibavirinmedicineHumansCombination therapyHepatologybiologybusiness.industryRibavirinfibrosisInterferon-alphavirus diseasesDrug ToleranceHepatitis CHepatitis C ChronicMiddle Agedbiology.organism_classificationmedicine.diseaseRecombinant Proteinsdigestive system diseasesMulticenter trial; Combination therapy; fibrosischemistryMulticenter trialImmunologyPeginterferon alfa-2bFemaleSafetybusinessmedicine.drugJournal of Hepatology
researchProduct

Combination therapy with amantadine and interferon in naı̈ve patients with chronic hepatitis C: meta-analysis of individual patient data from six cli…

2003

Abstract Background/Aims In chronic hepatitis C, clinical trials evaluating the efficacy of amantadine (AMA) and interferon (INF) compared to INF monotherapy, have produced conflicting results. We performed a meta-analysis of the individual patient's data from previous studies. Methods Nine hundred and seventy-two patients from six European centres were evaluated by means of individual patient meta-analysis, using mixed models with centres and the centre–treatment interaction fitted as random variables. Results At the end of therapy, virological responses were 38.5% (95% CI 34.1–42.8) after INF and AMA, and 29.5% (95% CI 25.5–33.6) after INF alone (P=0.003). Sustained response occurred in 1…

AdultMalemedicine.medical_specialtyGenotypeCombination therapyHepacivirusAntiviral AgentsGastroenterologymeta-analysilaw.inventionchemistry.chemical_compoundPharmacotherapyRandomized controlled triallawInternal medicineparasitic diseasesAmantadinemedicinechronic hepatitis CHumansAgedRandomized Controlled Trials as TopictherapyDose-Response Relationship DrugHepatologybusiness.industryRibavirinAmantadineAlanine TransaminaseinterferonHepatitis CHepatitis C ChronicMiddle AgedViral Loadrandomized clinical trialmedicine.diseaseClinical trialTreatment OutcomechemistryImmunologyDrug Therapy CombinationFemaleInterferonsbusinessViral loadmedicine.drugJournal of Hepatology
researchProduct

Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial

2008

It was hypothesized that in hepatitis C virus (HCV) genotype 1 patients, variable treatment duration individualized by first undetectable HCV RNA is as effective as standard 48-week treatment. Patients (n_696) received peginterferon alfa-2a, 180 mg/week, or peginterferon alfa-2b, 1.5 mg/kg/week, plus ribavirin, 1000-1200 mg/day, for 48 weeks (standard, n _237) or for 24, 48, or 72 weeks if HCV-RNA–negative at weeks 4, 8, or 12, respectively (variable, n _ 459). Sustained virologic response (SVR) was achieved in 45.1% [95% confidence interval (CI) 38.8-51.4] of the patients in the standard group and in 48.8% (CI 44.2-53.3) of the patients in the variable group (P _ 0.37). The percentages of …

AdultMalemedicine.medical_specialtyGenotypeHepatitis C virusAlpha interferonHepacivirusInterferon alpha-2medicine.disease_causeAntiviral AgentsGastroenterologyDrug Administration SchedulePolyethylene Glycolslaw.inventionchemistry.chemical_compoundRandomized controlled triallawInternal medicineRibavirinmedicineHumansProspective StudiesRapid Virologic Responsegenotype 1Hepatologybusiness.industryRibavirinStandard treatmentInterferon-alphavirus diseasesHepatitis CMiddle Agedmedicine.diseaseRecombinant Proteinsdigestive system diseasesConfidence intervalSurgeryTreatment OutcomechemistryRNA ViralDrug Therapy CombinationFemalehepatitis Cbusiness
researchProduct